TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
Top Cited Papers
- 1 October 2003
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 9 (10) , 1245-1250
- https://doi.org/10.1038/nm939
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)Gastroenterology, 1995
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritisThe Lancet, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Structure and expression of a cloned cDNA for human interleukin-2Nature, 1983
- RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATIONThe Lancet, 1981